{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T13:40:31Z","timestamp":1774014031066,"version":"3.50.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Sublingual immunotherapy (SLIT) has been increasingly used instead of subcutaneous immunotherapy. SLIT was initially approved for use among adults; however, it has become more widely accepted for children. Few studies have evaluated the effectiveness of SLIT in the treatment of dust mite allergies among children, including adverse effects. This study aimed to investigate the effectiveness of SLIT in children with dust mite allergies, as well as its adverse effects, at a pediatric general outpatient clinic.<\/jats:p>\n            <jats:p>I analyzed the data of 181 patients aged 4 to 12\u200ayears who tested positive for mite antigen-specific immunoglobulin E, exhibited nasal and\/or eye symptoms, and received Miticure. Symptoms were evaluated using the Japanese rhino-conjunctivitis quality of life (QOL) questionnaire no. 1. Wilcoxon tests were used to compare the pretreatment and post-treatment symptom scores. Adverse events were tallied, and Kaplan\u2013Meier curves and Wilcoxon tests were used to assess the proportion of dropouts.<\/jats:p>\n            <jats:p>The mean QOL score at the baseline was 2.17 (standard deviation [SD] 1.45). After 1\u200aweek, the mean symptom QOL score was 1.63 (SD 1.32); the lowest mean score was found in week 41 (0.48, SD 0.63). A significant decline in the occurrence of all symptoms, including sneezing, nasal discharge, nasal congestion, itchy eyes, and teary eyes, was observed. Adverse effects were observed in 76 (42.0%) patients; the most common adverse effect was itchy mouth.<\/jats:p>\n            <jats:p>SLIT improves symptoms with minimal adverse effects in pediatric patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028690","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T14:03:39Z","timestamp":1643378619000},"page":"e28690","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Sublingual immunotherapy for pediatric patients with mite allergies"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4068-3921","authenticated-orcid":false,"given":"Teruyuki","family":"Kajiume","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaip.2016.07.013","article-title":"Dust mite-induced perennial allergic rhinitis in pediatric patients and sublingual immunotherapy","volume":"5","author":"Anderson","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12519-011-0242-3","article-title":"Dendritic cells modification during sublingual immunotherapy in children with allergic symptoms to house dust mites","volume":"7","author":"Angelini","year":"2011","journal-title":"World J Pediatr"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0091-6749(97)70203-3","article-title":"Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings","volume":"100","author":"Bagnasco","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ppul.1088","article-title":"Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study","volume":"32","author":"Bahceciler","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jaci.2007.06.013","article-title":"Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation","volume":"120","author":"Bohle","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0091-6749(90)90048-9","article-title":"Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay","volume":"85","author":"Bousquet","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper","volume":"102","author":"Bousquet","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jaip.2021.02.029","article-title":"Controversies in allergy: a Pro\/Con review of sublingual allergen immunotherapy and allergic asthma","volume":"9","author":"Calder\u00f3n","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/WOX.0b013e3181c6c379","article-title":"Sub-lingual immunotherapy: world allergy organization position paper 2009","volume":"2","author":"Canonica","year":"2009","journal-title":"World Allergy Organ J"},{"issue":"(Suppl 1)","key":"R10-20250504","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1020.e10","DOI":"10.1016\/j.jaci.2020.07.036","article-title":"A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial","volume":"147","author":"Demoly","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1365-2222.2009.03448.x","article-title":"Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic\/rhinitis children sensitized to house dust mite: an open randomized controlled trial","volume":"40","author":"Eifan","year":"2010","journal-title":"Clin Exp Allergy"},{"issue":"(Suppl 1)","key":"R13-20250504","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.3109\/00016489.2012.660732","article-title":"Clinical efficacy of sublingual immunotherapy in pediatric patients with allergic rhinitis sensitized to house dust mites: comparison to adult patients","volume":"132","author":"Han","year":"2012","journal-title":"Acta Otolaryngol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2332\/allergolint.13-OA-0570","article-title":"Determining minimal clinically important differences in Japanese cedar\/cypress pollinosis patients","volume":"62","author":"Higaki","year":"2013","journal-title":"Allergol Int"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0091-6749(91)90134-A","article-title":"Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells","volume":"87","author":"Iliopoulos","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"R16-20250504","first-page":"01250-2","article-title":"Efficacy of house dust mite sublingual immunotherapy in patients with atopic dermatitis: a randomized, double-blind, placebo-controlled trial","author":"Langer","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ACI.0b013e328329a2a9","article-title":"Sublingual immunotherapy in children: complete and updated review supporting evidence of effect","volume":"9","author":"Larenas-Linnemann","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e0182295","DOI":"10.1371\/journal.pone.0182295","article-title":"Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children","volume":"12","author":"Lim","year":"2017","journal-title":"PLoS One"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1111\/all.13544","article-title":"Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children","volume":"73","author":"Masuyama","year":"2018","journal-title":"Allergy"},{"key":"R20-20250504","first-page":"375","article-title":"Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period","volume":"17","author":"Nuhoglu","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/pai.12984","article-title":"Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: a randomized trial in a pediatric population","volume":"30","author":"Okamoto","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"(Suppl 1)","key":"R22-20250504","first-page":"70","article-title":"Preparation of Japanese versions of rinoconjunctivitis quality of life questionnaire (RQLQ) and work productivity and activity impairment questionnaire (WPAI-AS)","volume":"52","author":"Okuda","year":"2003","journal-title":"Arerugi"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/ACI.0000000000000112","article-title":"Sublingual immunotherapy in children: the recent experiences","volume":"14","author":"Pleskovic","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5409\/wjcp.v5.i1.47","article-title":"Sublingual immunotherapy for pediatric allergic rhinitis: the clinical evidence","volume":"5","author":"Poddighe","year":"2016","journal-title":"World J Clin Pediatr"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/all.13658","article-title":"Preventive sublingual immunotherapy with house dust mite extract modulates epitope diversity in pre-school children","volume":"74","author":"Ponce","year":"2019","journal-title":"Allergy"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13601-020-00315-0","article-title":"Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis","volume":"10","author":"Proctor","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/1060028018769443","article-title":"House dust mite sublingual immunotherapy for pediatric patients with allergic asthma","volume":"52","author":"Richards","year":"2018","journal-title":"Ann Pharmacother"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM199008233230802","article-title":"Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study","volume":"323","author":"Sporik","year":"1990","journal-title":"N Engl J Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.aller.2017.09.022","article-title":"Efficacy and safety of sublingual immunotherapy with Dermatophagoides farinae drops in pre-school and school-age children with allergic rhinitis","volume":"46","author":"Tang","year":"2018","journal-title":"Allergol Immunopathol (Madr)"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JCMA.0000000000000231","article-title":"House dust mite-specific immunotherapy alters the natural course of atopic march","volume":"83","author":"Tang","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"R31-20250504","article-title":"House dust mite SLIT-tablet is well tolerated in pediatric patients with controlled asthma","author":"Tanida","year":"2021","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2332\/allergolint.10-OA-0200","article-title":"Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children","volume":"59","author":"Yonekura","year":"2010","journal-title":"Allergol Int"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"333","DOI":"10.12659\/MSM.911982","article-title":"Efficacy of sublingual administration of dermatophagoides farinae drops for treatment of pediatric allergic rhinitis accompanied by adenoid hypertrophy and improvement of immune function","volume":"25","author":"Yu","year":"2019","journal-title":"Med Sci Monit"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"233","DOI":"10.12932\/AP0276.31.3.2013","article-title":"Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy","volume":"31","author":"Yukselen","year":"2013","journal-title":"Asian Pac J Allergy Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:27:34Z","timestamp":1746332854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028690","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"2021-09-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}